CereGate

CereGate is a startup based in Germany. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

CereGate develops minimally invasive computer-brain interface technology aimed at treating neurological disorders and restoring sensory and motor functions; the technology has been clinically tested in over 85 patients addressing movement, balance, and sensory impairments.